Life Sciences CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS)… AIT News Desk May 23, 2022 Collaborative initiative leverages CENTOGENE’s differentiated diagnostic expertise with testing performed in over 650,000 individuals globally…
Cloud MBMV Invests in International Bio-Tech Startup Arcensus GmbH AIT News Desk Feb 23, 2022 Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases…
Blockchain CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19 AIT News Desk Apr 17, 2020 CENTOGENE, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for…